ALK-Abelló
ISIN: DK0061802139 | Ticker: ALK
At ALK, we go to work every day to make a difference for the many people with allergy around the world. It is our ambition to make life with allergy surprisingly simple for as many people as possible, and we build upon our strong heritage as a pioneer in allergy immunotherapy, when we continue to innovate, develop and market new products and solutions to help improve the health of people with allergy.
Every day, our employees contribute to our aspiration of becoming the world leader in allergy by coming to work to do their best in the pursuit of providing new and better allergy treatments and solutions. We work in a high-energy, international setting where it is imperative that our people thrive and develop. Creativity, influence and opportunities are key elements in developing our people.
ALK is a global company with production sites in Denmark, France, Spain and the United States. ALK was founded in Copenhagen in 1923 and today we employ around 2,300 people around the world.
1923
Served areaWorldwide
Headcount2,300
HeadquartersBøge Allé 6-8, 2970 Hørsholm – Denmark
202,567,200
IPOJan. 1, 2000
Stock exchange(s)Nasdaq Copenhagen